Transcriptional repression of NFKBIA triggers constitutive IKK- and proteasome-independent p65/RelA activation in senescence by Kolesnichenko, M. et al.
Article
Transcriptional repression of NFKBIA triggers
constitutive IKK- and proteasome-independent
p65/RelA activation in senescence
Marina Kolesnichenko1,* , Nadine Mikuda1, Uta E H€opken2, Eva K€argel1, Bora Uyar3 ,
Ahmet Bugra Tufan1, Maja Milanovic4 , Wei Sun5,† , Inge Krahn1, Kolja Schleich4, Linda von Hoff1,
Michael Hinz1, Michael Willenbrock1, Sabine Jungmann1, Altuna Akalin3 , Soyoung Lee4,
Ruth Schmidt-Ullrich1 , Clemens A Schmitt4 & Claus Scheidereit1,**
Abstract
The IjB kinase (IKK)-NF-jB pathway is activated as part of the
DNA damage response and controls both inflammation and resis-
tance to apoptosis. How these distinct functions are achieved
remained unknown. We demonstrate here that DNA double-strand
breaks elicit two subsequent phases of NF-jB activation in vivo
and in vitro, which are mechanistically and functionally distinct.
RNA-sequencing reveals that the first-phase controls anti-apop-
totic gene expression, while the second drives expression of senes-
cence-associated secretory phenotype (SASP) genes. The rapidly
activated first phase is driven by the ATM-PARP1-TRAF6-IKK
cascade, which triggers proteasomal destruction of inhibitory IjBa,
and is terminated through IjBa re-expression from the NFKBIA
gene. The second phase, which is activated days later in senescent
cells, is on the other hand independent of IKK and the proteasome.
An altered phosphorylation status of NF-jB family member p65/
RelA, in part mediated by GSK3b, results in transcriptional silencing
of NFKBIA and IKK-independent, constitutive activation of NF-jB in
senescence. Collectively, our study reveals a novel physiological
mechanism of NF-jB activation with important implications for
genotoxic cancer treatment.
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Introduction
Chemo- and radiotherapies activated oncogenes and shortened
telomeres trigger via the DNA damage response (DDR) a terminal
proliferative arrest called cellular senescence (Blagosklonny, 2014;
Salama et al, 2014; Lasry & Ben-Neriah, 2015; Lee & Schmitt, 2019).
The associated alterations include formation of senescence-associ-
ated heterochromatin foci (SAHF), increased synthesis of cell cycle
inhibitors, including p21 (CDKN1A) and p16 (CDKN2A) and of
inflammatory cytokines and chemokines that constitute the senes-
cence-associated secretory phenotype (SASP) and a related, low-
grade inflammation termed senescence inflammatory response (SIR)
that affects surrounding tissues in a paracrine manner (Shelton
et al, 1999; Lasry & Ben-Neriah, 2015). The epigenetically controlled
cell cycle cessation serves as a cell-autonomous barrier to tumor
formation (Braig et al, 2005; Collado et al, 2005; Reimann et al,
2010). Therefore, induction of senescence was considered as impor-
tant in treating cancer and other pathologies. The inflammatory
response, however, comprises factors that may instigate oncogenic
transformation, cell migration, and cancer stemness (Acosta et al,
2008; Reimann et al, 2010; Chien et al, 2011; Freund et al, 2011;
Jing et al, 2011; Acosta et al, 2013; Salama et al, 2014; Hoare et al,
2016; Milanovic et al, 2018).
The majority of SASP factors are transcriptional targets of NF-jB
(Acosta et al, 2008; Kuilman et al, 2008; Chien et al, 2011; Freund
et al, 2011; Jing et al, 2011; Lasry & Ben-Neriah, 2015). Although it
is well established that NF-jB drives inflammatory gene expression
in senescence, whether it also contributes to cell cycle arrest
remained unclear. DNA double-strand breaks lead to rapid activa-
tion of NF-jB RelA/p65-p50, the most prevalent heterodimer
(Smale, 2012). A signaling cascade that is activated by ataxia
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telangiectasia mutated (ATM) and poly(ADP-ribose) polymerase 1
(PARP1), and also depends on TNFR-associated factor 6 (TRAF6),
converges on the IjB kinase (IKK) complex (Wu et al, 2006; Stil-
mann et al, 2009; Hinz et al, 2010). The latter is composed of the
regulatory IKKc subunit and the kinases IKKa and IKKb (Hayden &
Ghosh, 2012; Hinz & Scheidereit, 2014), which phosphorylate IjBa,
targeting it for degradation by the 26S proteasome. Liberated NF-jB
translocates to the nucleus and activates transcription of its target
genes, including NFKBIA, encoding IjBa (Hinz et al, 2012). This
negative feedback loop ensures that NF-jB activation is transient.
Replication-, oncogene-, and therapy-induced senescence is associ-
ated with unresolved DNA damage and with constitutive NF-jB acti-
vation (Rodier et al, 2009; Chien et al, 2011; Freund et al, 2011; Jing
et al, 2011).
Using cells of epithelial origin, both from transgenic mouse
models and from human primary and cancer cell lines, we
demonstrate here that DNA damage triggers two functionally
distinct phases of NF-jB activation. Although the first, immedi-
ately activated phase is IKK- and proteasome-dependent and acti-
vates anti-apoptotic gene expression, the second NF-jB activation
phase, occurring days later in senescence, is caused by a perma-
nent silencing of NFKBIA transcription and is thus IKK- and
proteasome-independent. We show that this second, IKK-
independent phase of NF-jB is responsible for SASP, but not for
the cell cycle arrest. Furthermore, SASP expression profile is
generated in vivo and ex vivo in the absence of DNA damage
solely by depletion of IjBa.
Results
DNA damage activates NF-jB in two distinct phases: a transient
anti-apoptotic first and a persistent inflammatory second phase
To investigate the kinetics of activation of NF-jB, we first examined
the establishment of senescence and SASP over time in human
diploid fibroblasts (HDFs) and cancer cell lines that experienced
DNA damage. Onset of senescence was marked by senescence-asso-
ciated b-galactosidase (SA-b-gal) activity and elevated CDKN1A
(p21) expression (Fig 1A and Appendix Fig S1A). Proliferation
ceased 1–2 days following irradiation (IR), as expected, and cells
entered a lasting senescent state (Appendix Fig S1B and C). Unre-
solved DNA damage, evidenced by cH2AX foci and phosphorylation
of p53 at serine 15, was seen within minutes and hours and
persisted through all time points. However, acute activation of
upstream ATM and Checkpoint kinase 2 (Chk2) was observed
predominantly only within minutes and hours after the IR treatment
(Appendix Fig S1D and E). Strikingly, a single dose IR generated a
biphasic NF-jB activation, with two temporally separate phases of
its nuclear translocation and DNA binding, first, within hours and
then days later (Fig 1B, and Appendix Fig S1D, F and G). An RNA-
seq analysis revealed distinct transcriptomes in both NF-jB phases
(Fig 1C and Tables EV1A–C). During the first phase, 326 transcripts
showed significant upregulation (Dataset EV1A), which included
direct targets of NF-jB, such as early response genes and negative
feedback inhibitors of the pathway (NFKBIA and TNFAIP3;
see Dataset EV1B). This transcript group was enriched for GO
terms “cell cycle arrest” and “regulation of apoptotic process”
(Table EV1). In contrast, the 2,980 transcripts upregulated during
the second phase were enriched for GO terms “inflammatory
response”, “immune response”, and “response to wounding”
(Table EV1). The biphasic NF-jB response thus coincided with two
distinct transcriptomes, an anti-apoptotic first phase and a pro-
inflammatory second phase.
We next analyzed murine tissues for IR-induced expression of
the representative first- and second-phase target genes of NF-jB,
Nfkbia and Il6, respectively. IR strongly activates NF-jB in various
tissues (Li et al, 2001). Indeed, IR significantly induced Nfkbia
mRNA in skin and kidney tissues only at early time points and of Il6
mRNA only at late ones, representing the first and second NF-jB
phases (Fig 1D). Other examples for induced phase-restricted gene
expression in skin are Tnfaip3 (only first phase) and Ctsb or Cxcl3
(only second phase; Appendix Fig S1H).
To ensure that the expression of SASP during the second phase
depended on NF-jB, we analyzed primary kidney cells from irradi-
ated mice, which ubiquitously express the NF-jB super-repressor
IjBaDN (Krappmann et al, 1996; Schmidt-Ullrich et al, 2001).
Compared to littermate controls, expression of Il6 in the second
phase was abolished, whereas Cdkn1a and Cdkn2a upregulation
was unaffected (Appendix Fig S1I). These results further reveal that
DNA damage activates NF-jB that drives SASP, but NF-jB is not
essential for the proliferative arrest observed in senescence.
A strong response was seen in hair follicles (HF), which require
NF-jB activation for development and morphogenesis (Schmidt-
Ullrich et al, 2001). Upregulation of Nfkbia mRNA and IjBa protein
was restricted to the first phase of NF-jB activation in HF following
whole-body IR (Fig 1E and F). At Day 7 post-IR, IjBa expression in
the proximal HF was strongly reduced, concomitant with an
increase in IL-6 expression in the same region (Fig 1G and H). These
results demonstrate that two distinct, subsequent NF-jB transcrip-
tional programs also occur in vivo. Because IjBa is required to
terminate NF-jB signaling, we postulated that loss of IjBa in senes-
cence could trigger SASP.
Loss of IjBa expression in senescence triggers the second phase
of NF-jB activation and generates SASP
IjBa expression was either undetectable or strongly reduced in
senescence in the different cancer- and non-transformed cell lines
tested (Fig 2A and Appendix Fig S2A and B). Likewise, NFKBIA
mRNA was upregulated only in the first phase (Fig 2A, right panel;
Appendix Fig S2C), despite robust activation of NF-jB in both
phases (Fig 1B). Repeat IR treatment, with the aim to re-stimulate
first-phase-like transcriptional induction of NFKBIA in senescent
cells, restored neither NFKBIA mRNA nor IjBa protein expression
(Fig 2A left, lane 5, and right panel).
Activated oncogenes cause DNA strand breaks and induce DDR
signaling, thereby promoting cellular senescence similar to cells
exposed to DNA-damaging agents (Acosta et al, 2008; Coppe et al,
2008; Kuilman et al, 2008). Inducible activation of oncogenic
RASV12 led to activation of NF-jB and expression of the
representative SASP factor IL-8 (encoded by CXCL8) that negatively
correlated with IjBa expression (Appendix Fig S2D and E). In
summary, these data show that different pro-senescent triggers lead
to loss of NFKBIA mRNA expression together with the onset of an
NF-jB-driven SASP.
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To investigate if experimental NFKBIA depletion mimics the
second-phase NF-jB activation and SASP type gene expression, we
knocked down NFKBIA (Fig 2B and Appendix Fig S2F). We
confirmed that DNA damage signaling was not altered due to
NFKBIA knockdown (Appendix Fig S2F), and importantly, that
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knockdown (Fig 2B, lane 5) did not stem from a DDR (Appendix Fig
S2F). These data indicate that knockdown of NFKBIA, irrespective
of DNA damage, is sufficient for constitutive NF-jB activation.
We next asked which target genes would be regulated by consti-
tutive NF-jB activation resulting from NFKBIA knockdown. Remark-
ably, the transcriptome of non-irradiated NFKBIA-depleted cells
shared a strong overlap and the same GO terms with the senescent
cells of the second phase (Fig 2C and D, and Table EV1). Thus, loss
of IjBa in the absence of DNA damage was sufficient to activate
transcription of SASP factors. IjBa rescue through ectopic overex-
pression of an NFKBIA mutant encoding the proteasome-insensitive
IjBaS32AS36A blocked the induction of the bona fide SASP factors
(Appendix Fig S2G), consistent with the conclusion that loss of IjBa
drives expression of SASP. Secretion of a set of the identified cytoki-
nes and chemokines was confirmed by an antibody array
(Appendix Fig S2H). Furthermore, supernatants from either senes-
cent or IjBa-depleted cells induced migration of macrophages
(Appendix Fig S2I).
Since we showed that suppression of NFKBIA was sufficient for
SASP, we next asked whether it was also sufficient for senescence-
associated proliferative arrest. At least in the case of El-myc
lymphomas, it has been suggested that NF-jB also positively regu-
lates cell cycle arrest (Chien et al, 2011). We therefore analyzed
proliferation of cells with NFKBIA knockdown. The duplication rate
of cells with NFKBIA knockdown was comparable to that of control
cells (Appendix Fig S3A). Similarly, BrdU incorporation in senescent
cells with NFKBIA knockdown was not affected, despite constitutive
activation of NF-jB (Appendix Fig S3B).
We next asked whether in vivo, constitutive NF-jB resulting
from a knockout of Nfkbia would also trigger SASP, but not senes-
cence-associated proliferative arrest. Since ubiquitous loss of IjBa
causes early postnatal lethality (Beg et al, 1995; Klement et al,
1996), we generated intestinal epithelium-restricted (villin-
Cre × floxed Nfkbia) knockout mice (Mikuda et al, 2020). Impor-
tantly, we observed hyperproliferation of cells, leading to crypt
hyperplasia and enrichment of genes responsible for cell cycle
progression. Increased proliferation (evidenced by increase in Ki67+
cells) was observed both in vivo and in organoids derived from
these mice (Mikuda et al, 2020). Thus, constitutive NF-jB activation
in vivo regulates proliferation and cell cycle progression in a positive
manner. To determine if SASP factors could be detected in vivo, we
performed GSEA analysis on epithelium from (villin-Cre × floxed)
Nfkbia knockout mice and matched sibling controls (Fig 2E). Impor-
tantly, only enrichment of SASP-coding transcripts was detected,
but not of those transcripts belonging to the broader category of
cellular senescence, which in addition comprises factors involved in
cell cycle regulation (Fig 2E and Appendix Fig S3C). We confirmed
our findings by RT–qPCR by analyzing expression of selected SASP
factors that are also targets of NF-jB, including Ccl20, Icam1, Il6
and Tnfa (Fig 2F). These were significantly upregulated in the
absence of DNA damage, evidenced by lack of p53 pSer15 nuclear
foci (Appendix Fig S3D and E), confirming our conclusion in an
in vivo setting.
p65 regulates SASP in senescence but not proliferative arrest
Since we observed distinct NF-jB targets upregulated during the
two phases (Dataset EV1B), we next asked which family member(s)
were responsible for NF-jB activity in senescence. NF-jB showed
robust DNA binding during both the first and the second phase
(Fig 3A, lanes 7 and 13), consisting in each case of p65-containing
heterodimers (lanes 10 and 16). We therefore knocked down RELA/
p65 to analyze how it regulates the first and the second-phase tran-
scriptomes. All NF-jB targets, including SASP-encoding genes,
showed decrease in expression (Fig 3B) in cells bearing shRNA
against RELA/p65 (Appendix Fig S4A). Nevertheless, knockdown
of RELA did not rescue cells from senescence (Fig 3C and
Appendix Fig S4A–C). These data confirm that p65 containing
dimers regulate SASP but not the senescence-associated proliferative
arrest.
Suppression of NFKBIA in senescence through p65 pSer468
Since loss of IjBa in the second phase resulted from a decline of
mRNA expression, we investigated its regulation by p65. The
phosphorylation status of this subunit differentially determines
◀ Figure 1. NF-jB is activated in two distinct phases in response to DNA damage corresponding to anti-apoptotic and pro-inflammatory gene programs.
A SA-b-gal staining of U2-OS cells, harvested at indicated times post-irradiation (IR); h, hours; D, days; UT, untreated. n = 3. Scale bar: 50 lm. Bar graph: Significance
was determined by Brown–Forsythe ANOVA with Dunnett’s 3T test, using n = 3 biological replicates. SD shown. ***P < 0.001, n.s., not significant.
B Nuclear fractions from U2-OS cells were harvested at indicated time points post-IR (20 Gy) as in (A). Top panel: NF-jB DNA binding was analyzed by EMSA. Lower
panels: Western blot of indicated NF-jB subunits and PARP1 as loading control. The two phases of nuclear translocation and DNA binding are indicated.
Representative gel shown from n = 5 biological replicates.
C Gene expression analysis of two NF-jB phases following damage. RNA-seq analysis (n = 5 biological replicates per group) of U2-OS cells, either untreated or analyzed
1.5 h or 7 days after irradiation (20 Gy), as indicated. The heatmap shows significantly regulated genes (log2 value > 0.5 and P value < 0.05). Black arrow points to
NFKBIA. Significance determined by ANOVA with Bonferroni correction for multiple testing. See also Dataset EV1.
D Female mice, 12–16 weeks old (n = 6 mice per condition (with three technical repeats per mouse), were irradiated (5 Gy) and sacrificed after 1 h (first phase), 7 days
(second phase) or left untreated. Skin or renal tissue RNA was analyzed by RT–qPCR, shown as a mean  SD. Significance was confirmed by ANOVA with Tukey
multiple comparisons test. SD shown: *P < 0.05, **P < 0.01.
E In situ hybridization using an anti-sense IjBa/Nfkbia riboprobe on longitudinal skin sections from female mice treated as in (D) for the time indicated. Representative
sections shown from n = 6 mice per condition. Bu, bulge region (dashed lines), HS, hair shaft, IFE, interfollicular epidermis. Scale bar: 50 lm.
F Quantitation of (E) from n = 6 mice per condition and 3–4 sections per mouse. Bulge regions positive for Nfkbia were counted and presented as percentage of total.
One-way ANOVA analysis with Tukey multiple comparisons test was performed. SD shown. **P < 0.01.
G Skin sections as in (E) analyzed by immunofluorescence with IjBa (red) or IL-6 antibody (green) and nuclear DAPI staining (blue). Dotted lines delineate hair follicles,
Bu, bulge region, HS, hair shaft, IFE, interfollicular epidermis, SG, sebaceous gland. Scale bar: 50 lm.
H Quantitation of (G) from n = 6 mice per condition and 3–4 sections per mouse. Bulge regions positive for IjBa or IL-6 were counted and presented as percentage of
total. One-way ANOVA analysis with Tukey multiple comparisons test was performed. SD shown. *P < 0.05, ***P < 0.001.
Source data are available online for this figure.
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transcription of its target genes (Schmitz et al, 2004; Wietek &
O’Neill, 2007). We therefore analyzed the phosphorylation status of
p65 during the two phases (Fig 4A). Phosphorylation on p65
Ser536, the substrate site of IKK, peaked during the first phase and
declined in the second. Unlike phosphorylation of p65 at S536 and
S276, which enhance the p65 transactivation potential, phosphory-
lation at S468 is inhibitory and is mediated in part by GSK3b (Buss
et al, 2004; Christian et al, 2016). Of note, GSK3b exhibits increased
kinase activity in senescence to activate formation of SAHF, through
downregulation of Wnt signaling (Ye et al, 2007). Indeed, nuclear
phosphorylation on S468 increased in senescence (Fig 4A left and
right panels). To determine if phosphorylation on S468 repressed
expression of IjBa, we overexpressed p65 bearing a S468A mutation
in cells where endogenous p65 was knocked down. Overexpression
of p65 S468A rescued IjBa expression (Fig 4B). Similar results were
observed with ectopic expression of wild-type p65, likely due to the
abundance of the substrate in relation to the S468 kinase(s). As a
negative control, we transfected the S276A mutant. Since phospho-
rylation at S276 is required for p65 activity (Christian et al, 2016),
its overexpression did not rescue IjBa in senescence (Fig 4B).
This model strongly predicts that the NFKBIA locus is bound
during the second but not the first phase by inhibitory p65, which is
phosphorylated at serine 468. To explore this possibility, we
performed chromatin immunoprecipitation (ChIP) with both p65
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Figure 2.
◀ Figure 2. Knockdown of NFKBIA in cell lines and knockout in vivo mimicssecond-phase NF-jB activity and triggers SASP.
A Left panel: IjBa Western blot of U2-OS cells. Lane 1, untreated (ut); Lanes
2–4, single IR (20 Gy) at indicated time points prior to harvest; Lane 5, IR at
5 days prior to harvest, plus 1.5 h prior to harvest. Right panel: Samples
treated as in the left panel, analyzed by RT–qPCR. Significance from n = 3
replicates per condition determined by ANOVA analysis with Tukey multiple
comparisons test. SD shown. ***P < 0.001.
B NFKBIA knockdown by Dox-inducible shRNA in U2-OS cells. Cells were pre-
treated with Dox to induce knockdown. For knockdown efficiency see Fig
S2F. Cells were irradiated (20 Gy) or not, as indicated and described above.
NF-jB activity was analyzed by EMSA. ns, non-specific band. A
representative gel from n = 3 biological replicates is shown.
C Venn diagram of RNA-seq analysis of genes activated following irradiation
in the first and second NF-jB activity phases or following shRNA-mediated
NFKBIA knockdown in non-irradiated cells (as in B). Numbers of overlapping
genes are shown in red. Hypergeometric probability calculation showed
significance between overlaps (adjusted with Bonferroni correction for
multiple testing). SD shown. ***P < 0.001.
D Top GO terms obtained using DAVID Functional Annotation Bioinformatics
Microarray 6.7 for first and second-phase genes and genes activated upon
NFKBIA knockdown, as in (C), as indicated.
E GSEA was performed comparing the IjBa IEC-KO gene list (n = 4 villin-
Cre × floxed IjBa mice and n = 4 littermate controls (GSE 139251) (Mikuda
et al, 2020), with a gene signature based on a list of SASP factors (Coppe
et al, 2010). NES: normalized enrichment score. FDR: false discovery rate.
F RT–qPCR analysis of indicated genes was performed using RNA extracted
from the duodenum of 5- and 8-week-old control villin-Cre (n = 6) or villin-
Cre x floxed IjBa mice (n = 6) both male and female. Expression is shown
as fold change between littermates, paired t-test. SD shown. *P < 0.05
**P < 0.01.
Source data are available online for this figure.
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which showed equivalent binding affinity during both phases, only
p65 pSer468 showed strongly induced binding during the second
phase (Fig 4C). Together, these data show that translational modifi-
cations on p65 lead to repression of its inhibitor-encoding gene,
NFKBIA, in senescence.
To determine which kinases could contribute to the phosphoryla-
tion of S468, we analyzed the nuclear fraction of cells with a
proteome kinase array. Of 45 selected kinases and proteins, 12
showed a significant change in response to IR (Fig 4D). As expected,
factors associated with DNA damage, including p53 and Chk2,
showed increased phosphorylation following irradiation, albeit with
differing kinetics (Fig 4D). Phosphorylation of GSK3a and b at the
inhibitory sites, serine 21 and 9, respectively, was present in
untreated cells and at 1.5 h post-IR, but was decreased in senes-
cence, indicating that nuclear GSK was more active. This correlated
with decreased abundance of b-catenin (Fig 4D), whose phosphory-
lation by GSK leads to its degradation (Kitagawa et al, 1999). Due to
the previously described role of GSK in phosphorylation of p65 on
serine 468, we knocked down GSK3b or inhibited GSK3b by lithium
chloride and CHIR-99021 (Fig 4E–G). Both modes of interference
diminished serine 468 phosphorylation and led to a partial restora-
tion of IjBa expression (protein and mRNA) in senescence, with
LOG2   
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Figure 3. RelA regulates SASP but not cell cycle arrest.
A Nuclear fractions from either untreated or irradiated (20 Gy) U2-OS cells, 1.5 h or 7 days prior to harvest, were analyzed by EMSA with supershift analysis. For
supershifting, lysates were incubated with antibodies or water, as indicated. Arrows point to shift location of a given subunit, due to antibody binding. ns, non-
specific band. All antibodies were previously tested for supershift compatibility. Representative gel shown from n = 3 replicates.
B Expression of SASP targets of NF-jB obtained from RNA-seq analysis (Dataset EV1B), was quantitated using RT–qPCR from the shRNA (RELA) stably expressing U2-OS
cells. For knockdown efficiency, see Appendix Fig S4A. Cells were treated with doxycycline (Dox) to induce knockdown of p65. Heatmap represents targets normalized
to the untreated Scrambled control. Expression is shown as log2 change with P values < 0.05. Statistical analysis performed using ANOVA with Bonferroni correction
for multiple testing. First-phase and second-phase samples were irradiated (20 Gy) 1.5 h and 7 Days prior to harvest, respectively. Analysis based on n = 3 biological
replicates.
C Cell duplication was measured at time points indicated in U2-OS cells bearing either scrambled control or Dox-inducible shRNA against RELA (n = 3 biological
replicates). Treatment with Dox was initiated at 2 days prior to IR (20 Gy) or after IR. Statistical significance in total duplication number between groups at day 6 was
determined by ANOVA with Tukey multiple comparisons test. SD shown. *P < 0.05, ***P < 0.001.
Source data are available online for this figure.
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concomitant decrease in expression of IL6 (Fig 4G). These data
show that changes in p65 phosphorylation contribute to an attenua-
tion of NFKBIA expression in senescence.
Second-phase NF-jB activation in senescence is independent of
IKK signaling and the proteasome
We next investigated the contribution of the known regulators of
the genotoxic stress-induced IKK pathway (Fig 5A) in the two NF-
jB phases. The activation of ATM and IKK correlated only with the
first NF-jB phase and peaked in the first hours after IR followed by
a decline afterward (Fig 5B). We also found that TRAF6 depletion
only abrogated activation of the first, but not the second NF-jB
phase (Fig 5C). Expression of target genes of NF-jB, IL6 and IL1A,
in the second phase was completely unaffected by depletion of ATM
(Appendix Fig S5A and B). Furthermore, proteasomal inhibition
abrogated IR-induced IjBa destruction in the first NF-jB phase, but
not loss of IjBa in the second phase (Fig 5D). In line with this,
upregulation of the bona fide SASP component IL-1a was not
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We eliminated IKKb using CRISPR/Cas9 (Fig 5E). Loss of IKKb
impeded only first-phase NF-jB activation (Fig 5E, lanes 2 and 6).
Remarkably, IKKb was not required for the second phase of NF-jB
activation (Fig 5E, lanes 4 and 8).
Our conclusion was further corroborated by identification of
genes that depended on p65 expression (Fig 3B), yet showed unal-
tered expression in senescent cells with CRISPR mediated knockout
of IKBKB (Fig 5F). These IKK-independent genes encoded many
bona fide SASP factors, such as IL8 and metalloproteinases MMP1
and 3 (Fig 5F, lower half of the panel). Likewise, siRNA-mediated
IKKc depletion only diminished p65 nuclear translocation at 1.5 h,
but not 5 days following IR (Appendix Fig S5C). To determine if
CHUK/IKKa that regulates non-canonical signaling might regulate
SASP, we checked expression of select NF-jB targets following
CHUK knockdown (Appendix Fig S5D). No significant downregula-
tion of most SASP genes was detected.
All these data substantiate that the second phase of NF-jB activa-
tion is independent of the IKK cascade induced by DNA damage and
independent of proteasomal destruction of IjBa.
Discussion
Most NF-jB activation pathways depend on IKKs (Hoffmann &
Baltimore, 2006; Hinz & Scheidereit, 2014). Here we provide a
physiologically relevant context for IKK-independent activation of
NF-jB both in human cells lines and in murine models in vivo.
We found that in DNA damage-induced senescence of epithelial
cells, two interconnected events comprising a decline in IKK
phosphorylation and a drop in transcription of the inhibitor of
the pathway, NFKBIA (IjBa), initiate a persistent, IKK-indepen-
dent activation of NF-jB (Fig 6).
We and others have previously shown that irreparable DNA
damage leads to cellular senescence and to SASP driven by NF-jB
(Rodier et al, 2009; Chien et al, 2011; Jing et al, 2011). However,
since DNA damage triggers prompt activation of NF-jB, whose
immediate transcriptional targets do not feature SASP, it was not
clear how NF-jB could be responsible for two such drastically dif-
ferent transcriptomes arising from the same initial stimulus. Here
we demonstrated both in vivo and ex vivo that a single dose of DNA
damage sequentially activates two temporally and functionally
distinct transcriptomes of NF-jB, separated by a span of several
days. An anti-apoptotic first phase is driven by an ATM-, PARP-1-,
and TRAF6-dependent IKK signaling cascade (Stilmann et al, 2009;
Hinz et al, 2010), resulting in proteasomal destruction of IjBa. A
pro-inflammatory second phase occurs in senescence and comprises
SASP (Fig 6). Importantly, we demonstrate that the second phase of
NF-jB and expression of the majority of the SASP genes are both
IKK- and proteasome-independent. A fraction of transcripts that
were IKK-dependent in senescence could be regulated in an alterna-
tive manner that does not require phosphorylation in the activation
loop of IKKb. Indeed, we have recently shown that basal activity of
IKKb suffices for its interaction with EDC4 (Enhancer of Decapping
4) and for post-transcriptional stabilization and destabilization of
scores of transcripts, including of CXCL8 and TNFA (Mikuda et al,
2018). It is therefore possible that IKK-dependent regulation of some
SASP genes occurs at the level of their RNA stability. It is also possi-
ble that additional phosphorylation sites on IKK, not analyzed in
this paper, contribute to its activation and to regulation of IKK-
dependent genes expressed in senescence.
Interestingly, absence of IKK at the instant of DNA damage abol-
ishes only the first phase of NF-jB activation, but does not affect the
second phase. This suggests that the first phase is not required for
the second, and that the changes accumulated over time activate
distinct signaling pathways that enable the second phase of NF-jB.
In accordance with this, we show that post-translational modifi-
cations on p65 contribute to the two distinct transcriptomes. IKK
phosphorylates p65 on serine 536 within minutes following DNA
damage, however in senescence a switch in phosphorylation from
serine 536 to 468, and to recruitment of p65-pSer468 to the NFKBIA
locus, leads to repression of NFKBIA. GSK3b, which is hyperactive
in senescence (Ye et al, 2007), phosphorylates p65 at Ser 468.
◀ Figure 4. p65 Ser 468 phosphorylation in senescence inhibits NFKBIA expression.
A Nuclear (Nuc.) and cytoplasmic (Cyto.) fractions of U2-OS cells were analyzed at times indicated after IR exposure by SDS–PAGE Western blotting. PARP1 and LDHA
are fractionation controls and phospho-specific p65 signals are indicated. Representative gels from n = 3 biological replicates are shown. Right panel: quantitation of
nuclear p65 and phosphorylated p65 species (n = 3). Fold changes compared to untreated samples (ut) and time points post-IR are indicated on Y and X axes,
respectively.
B U2-OS cells treated with Dox to deplete endogenous p65 were irradiated (20 Gy) and transfected with plasmids encoding p65, p65-S276A or p65-S468A, as indicated.
Nuclear (N) and cytoplasmic (C) lysates were analyzed by SDS–PAGE at day 7 post-IR. Representative gel from n = 3 biological replicates is shown. PARP1 and a-
tubulin serve as fractionation and loading controls.
C ChIP performed with U2-OS cells irradiated (20 Gy) 1.5 h or 7 days prior to assay, or left untreated (UT). Normalized relative enrichment of NFKBIA is shown (relative
to input and two non-recruiting reference regions). Left panel: p65 antibody. n = 5 biological replicates with three technical repeats per biological replicate. Right:
Antibody against p65 pSer468. n = 2 biological replicates with three technical repeats per biological replicate. Statistical significance was determined by ANOVA with
Tukey multiple comparisons test. SD shown. *P < 0.05, **P < 0.01, ***P < 0.001.
D Kinase proteome array was performed with nuclear fractions of U2-OS cells that were either left untreated (UT) or irradiated (20 Gy) at time points indicated prior to
harvest. Kinase binding to membrane was quantitated (n = 2) and only significant results (P < 0.05) are shown. Significance was determined by ANOVA with Tukey
multiple comparisons test.
E U2-OS cells left untreated (ut) or irradiated (20 Gy) 7 days before harvesting, as indicated. Two days prior to harvest cells were transfected with siRNA against GSK3b
or scrambled control (Scr). Whole cell lysates were analyzed by SDS–PAGE and Western blotting. A representative example from n = 3 experiments is shown.
F U2-OS cells were left untreated or exposed overnight to 10 mM LiCl, with or without prior irradiation, as indicated, and analyzed as in (E). Representative data from
n = 3 experiments are shown.
G RT–qPCR of U2-OS cells irradiated (20 Gy) either 1.5 h or 7 days prior to harvest. CHIR denotes treatment with GSK3 inhibitor CHIR-99021 (10 nM overnight). DMSO
overnight treatment was used as control. Quantitation was performed and statistical significance obtained from n = 3 replicates, using ANOVA with Tukey multiple
comparisons test. SD shown. *P < 0.05, **P < 0.01, ***P < 0.001.
Source data are available online for this figure.
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However, inhibition of GSK3b did not completely reinstate IjBa
expression, indicating that additional kinases and/or epigenetic
changes may contribute to downmodulation of NFKBIA expression
in senescence.
Silencing of NFKBIA in senescence results in IKK-independent
and persistent activation of NF-jB (Fig 6). Consequently, the second
phase can be mimicked without induction of DNA damage by inacti-
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A 
Figure 5. The second phase is IKK- and proteasome-independent.
A Diagram showing DNA double-strand break (DSB) induced first-phase NF-jB activation through an ATM/TRAF6- and PARP1/PIASy-dependent IKK activation
mechanism (Wu et al, 2006; Stilmann et al, 2009; Hinz et al, 2010).
B SDS–PAGE Western blot of whole cell lysates of U2-OS cells irradiated (20 Gy) at time points indicated prior to harvest. ut, untreated. LDHA. Representative gel shown
from n = 4 biological replicates.
C U2-OS cells transfected with TRAF6 siRNA or scrambled control siRNA and TRAF6 and IKKb levels analyzed by Western blotting (top panels). NF-jB activity was
determined by EMSA in untreated cells (ut) and after IR at indicated time points (lower panel). ns, unspecific band. Representative gels are shown from n = 2
biological replicates.
D U2-OS cells were exposed to IR at indicated time points prior to harvest and analyzed by Western blotting for levels of IjBa, NIK, IL-1a, and PARP1. Treatment with
proteasomal inhibitor MG132 (10 lM) started 4 h prior to harvest. NIK serves as positive control for efficient proteasome inhibition. Quantitation from n = 4
biological replicates and SD is shown for IjBa (right panel). Brown–Forsythe ANOVA test: P = 0.0005.
E U2-OS CRISPR IKBKB knockout and control cell lines were irradiated (20 Gy) and harvested at indicated time points. NF-jB activity was analyzed by EMSA (lower
panel). ns indicates an non-specific band. Upper panel, Western blot analysis of actin and IKKb. Representative gels shown from n = 3 replicates.
F Irradiated U2-OS control and IKBKB knockout cells (as above) were analyzed by RT–qPCR at the time points indicated for expression of NF-jB target genes identified
by RNA-seq (Dataset EV1). Significantly regulated targets, cutoff set at P = 0.05 (as determined by ANOVA with Tukey multiple comparison), are shown.
Source data are available online for this figure.
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cultures and the murine knockout model. Nonetheless, the gene
expression repertoire of NFKBIA knockout or knockdown cell lines
does not encompass the entire senescent inflammatory response
likely because full-featured senescence relies on activation of
additional regulators including TORC1, MAPK, Toll like recep-
tors, Notch1/TGF-b, and C/EBPb, and also on epigenetic changes
that firmly establish proliferative arrest (Narita et al, 2011;
Kolesnichenko et al, 2012; Serrano, 2012; Herranz et al, 2015; Hoare
et al, 2016).
It was previously suggested that in addition to promoting SASP,
p65 reinforces cell cycle arrest in senescent El-myc lymphomas
expressing the anti-apoptotic protein Bcl-2 (Chien et al, 2011).
However, Bcl-2 was also shown to attenuate cell cycle progression
independently of its anti-apoptotic functions (Zinkel et al, 2006).
Our findings clearly demonstrate that although NF-jB negatively
regulates expression of several cell cycle genes, knockdown of p65
does not disturb the established cell cycle arrest in epithelial cells
and murine model described here (Dataset EV1A–C). Furthermore,
we did not observe establishment of senescence either in human cell
lines bearing knockdown or knockout of NFKBIA, or in the murine
mouse model. We therefore conclude that NF-jB mediates only the
inflammatory phenotype, but not the cell cycle arrest in senescence.
NF-jB is constitutively activated in a variety of cancer types
(Ben-Neriah & Karin, 2011). Deletion of the NFKBIA gene or low
expression of IjBa protein serves as a major mechanism of perma-
nent NF-jB activation in a non-classical form of glioblastoma,
where it is associated with poor prognosis in patients and resistance
to proteasome and IKK inhibitors in clinical trials (Idbaih et al,
2011; Takeuchi & Nawashiro, 2011; Kinker et al, 2016; Raizer et al,
2016). Importantly, classical SASP factors and NF-jB targets, such
as IL-8, IL-6, and metalloproteinases are constitutively expressed in
these tumors, where they are suggested to fuel tumor growth and
invasion (Puliyappadamba et al, 2014). Our results imply that in the
milieu of established senescence and concomitant loss of IjBa, inhi-
bition of the IKK-signalosome or the proteasome would be inef-
fective in suppressing SASP in tumor therapies. On a positive note,
direct inhibition of NF-jB would inhibit detrimental SASP, while
leaving the cell cycle arrest intact.
Materials and Methods
Transfection/transduction
pTRIPz clones IjBa, p65, IKKb, and IKKy and Scrambled or pGIPZ-
IjBa and pGIPZ-scrambled (Dharmacon, Lafayette, USA) were
transfected into HEK293T cells and supernatant used for transduc-
tion as described in manufacturer’s protocol (http://dharmacon.ge
lifesciences.com/uploadedfiles/resources/ptripz-inducible-lentiviral-
manual.pdf). Clonal selection was performed using puromycin.
Doxycycline hydrochloride was added daily (2 µg/ml, Sigma).
Unless specified otherwise, Dox treatment was done for 5–6 days
prior to harvest. As controls, cells inducibly expressing scrambled
shRNAs were treated with Dox.
CRISPR knockout cells were generated as described previously
(Mikuda et al, 2018).
Preparation of murine tissues from in vivo experiments
All mouse protocols in this study followed the regulatory standards
of the governmental review board (Landesamt Berlin), Reg. G007/
08, G-0029/15, G 0082/13, G0358/13, and X9013/11). B6;129P2-
Nfkbiatm1Kbp and Tg(Vil-cre)20Syr) mice were sacrificed at 5 or
8 weeks of age. Additionally, 12- to 16-week-old C57Bl6/N female
mice were sacrificed either 1.5 h or 7 days post-whole-body IR
(5Gy).
Nuclear cytoplasmic fractionation, Western Blot analysis,
and EMSA
Nuclear cytoplasmic fractionation, Western Blot analysis, and EMSA
performed as described previously (Mikuda et al, 2018).
In situ hybridization
In situ hybridization was performed as described previously (Sch-
midt-Ullrich et al, 2001).
Antibody array
Proteome profiler (R&D Systems) antibody array was performed on
1 ml of culture medium according to manufacturer’s protocol.
Quantitation was performed with FusionCapt Advanced software.
Kinase array
(R&D Systems) was performed on nuclear lysates according to
manufacturer’s protocol. Quantitation was performed with Fusion-
Capt Advanced software.
Quantitative RT–PCR
Quantitative RT–PCR (RT–qPCR) was performed using the CFX96
Real Time System (Bio-Rad) and GoTaq qPCR Master Mix
(Promega), using a minimum of two reference genes (TBP, Rpl13a,
HRTP1).
Figure 6. Schematic model of the two-phase NF-jB activation after DNA
damage.
DNA damage triggers two phases of NF-jB activation and two distinct
transcriptomes: anti-apoptotic and inflammatory. NF-jB is rapidly activated
through the known genotoxic stress-induced IKK cascade, resulting in
proteasome-dependent IjBa degradation and expression of first-phase target
genes, including IjBa. NF-jB activation in senescence is caused by a loss of
IjBa expression through a largely IKK- and proteasome-independent
mechanism and drives SASP expression.
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RNA-seq
RNA samples were prepared in quintuplicates and extracted using
Trizol reagent according to manufacturer’s instructions (Thermo
Fisher). Stranded mRNA sequencing libraries were prepared with
500 ng total RNA according to manufacturer’s protocol (Illumina).
The libraries were sequenced in 1 × 100 + 7 manner on HiSeq 2000
platform (Illumina).
Antibodies
For a list of antibodies, See Table EV2.
Data availability
The RNA-seq data from this publication have been deposited to the
GEO database (www.ncbi.nlm.nih.gov/geo) and assigned the identi-
fier GSE158743 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE158743).
Expanded View for this article is available online.
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